BioNTech SE (22UA.F) XETRA

96.45

-0.7(-0.72%)

Updated at August 18 08:59PM

Currency In EUR

Valuation

Market Cap26.13B
Enterprise Value16.62B
P/E Ratio-30
PEG Ratio2.01
Price/Sales Ratio8.49
Price/Book Ratio1.22
Enterprise/Revenue4.87
Enterprise/EBITDA-30.98

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-0.28
Operating Margin-0.39

Management Effectiveness

Return On Assets-0.04
Return On Equity-0.04

Income Statement

Revenue2.75B
Revenue/Share11.36
Gross Profit2.21B
EBITDA-367.1M
Net Income-665.3M
Diluted EPS-2.77

Balance Sheet

Total Cash14.11B
Total Cash/Share58.71
Total Debt293M
Total Debt/Equity0.02
Current Ratio10.18
Book Value Per Share78.75

Price History

52-Week Change18.13
52-Week High124.6
52-Week Low71
Moving Average 50 Days94.26
Moving Average 200 Days99.4

Statistics

Average Volume1,637
Shares Outstanding240.4M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A